Navigation Links
31 Million Americans Suffer From Sinus Infections
Date:12/13/2007

Homeopathics offer a safe, effective, and inexpensive alternative to common

antibiotic treatment

BERKELEY SPRINGS, W.Va., Dec. 13 /PRNewswire/ -- Recent studies indicate that standard antibiotics and steroid nose sprays provide little to no relief of symptoms associated with sinus infections. People suffering from sinus problems generally improved within about two weeks whether they took antibiotics, steroids, or placebos.

One such study appears in the Journal of the American Medical Association. Researchers randomly assigned 240 adults various treatments including amoxicillin, steroid nose spray and placebos. Patients on the drugs didn't get better more quickly than those using the placebos.

Antibiotics, particularly amoxicillin, are among the most commonly prescribed medicines for sinus infections. Amoxicillin can cause possible side effects including fever, flu symptoms, nausea, diarrhea, and possibly seizure, possible allergic reactions and drug interactions.

As indicated by the recent study, an individual seeking relief from a sinus infection could pay for a doctor's visit and a prescription without experiencing symptom relief. Instead, the person may suffer side effects from the prescribed antibiotics.

There is good news -- homeopathic medicine offers sinus sufferers a safe alternative free of side effects, allergic reactions, and drug interactions for less than the average co-pay for a doctor's visit.

Homeopathy is the second most widely used medicinal system in the world and it has been used safely and effectively for over 200 years. Unlike allopathic medicines, which suppress symptoms rather than curing, homeopathy supports the natural curative mechanisms within the body.

"The low cost of the medications and the rarity of adverse reactions make it (homeopathy) preferable, in most cases, to modern drugs. Furthermore, because the medicines are inexpensive, safe, and easy to use,
'/>"/>

SOURCE Washington Homeopathic Products
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. $1 Million Gift Boosts Downriver Community
10. £5 million investment in personalized medicines to cut patient deaths
11. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 NCPDP announced today ... Program. The program establishes a three-year commitment of strategic ... of 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder ... of NCPDP, “and this is a wonderful continuation and ... We can trace AmerisourceBergen back to our very first ...
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 ... Optimity) will present at the 24th ... at 1:15 p.m. MT in Scottsdale, AZ. WEDI, ... nation’s leading nonprofit authority on the use of ... exchange. Donald Graf, National Director of Telemedicine for ...
(Date:5/5/2015)... May 05, 2015 Viverae®, a ... Bard Inc., a leading multinational developer, manufacturer and ... fields of vascular, urology, oncology and surgical specialty ... Award. The Vanguard Award recognizes outstanding achievement ... programs among Viverae’s significant client base. , Viverae ...
(Date:5/5/2015)... Los Angeles, CA (PRWEB) May 05, 2015 ... to treat and actually prevent a variety of health ... Doc utilized this modern research to adopt clean eating ... preservatives and artificial dyes associated with over-consumption of fast ... eating diet plans easy to follow and report ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 MAP ... programs and revenue cycle management for addiction treatment facilities, ... as Vice President of Business Development. Mr. Mooney, who ... addiction treatment field, will be responsible for developing new ... distribution of MAP’s core products and new initiatives. , ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... from oocytes (eggs) cryopreserved by the vitrification method are ... those involving fresh oocytes, the 26th annual meeting of ... today. Dr. Ana Cobo, Cryobiology Unit director at Institut ... the results of her team,s research would make egg ...
... ... Presence Catering to Members in all 50 States. , ... (PRWEB) June 30, 2010 -- MedTouch , a leading provider ... revitalized online presence for Sterling Life Insurance Company . The new website includes a ...
... ... Ondine Biopharma Corporation, a medical technology company developing photodisinfection ... owned subsidiary, “Sinuwave Technologies Corporation”, dedicated to the development and ... market. The subsidiary will license technology developed by Ondine Biopharma ...
... ... shortest skirts at Wimbledon. , ... London (PRWEB) June 30, 2010 -- With the tennis season now firmly underway, leading voucher ... tennis players to reveal the top five shortest tennis skirts at Wimbledon this tournament., , ...
... Lexington Health Care ... facilities in the Chicago area. OnShift enabled the company to reduce overtime by 71% in ... ... and employee communication software, recently announced it had been selected by Lexington Health Care ( ...
... ... ... their independence from tobacco cigarettes with a new e-cigarette system offered exclusively from PrimeVapor.com., , ... for smokers who want an alternative to inhaling a lit tobacco cigarette that is ...
Cached Medicine News:Health News:Ongoing pregnancy rates from vitrified eggs as good as those from fresh 2Health News:MedTouch Launches Revitalized Website for Sterling Life Insurance Company 2Health News:MedTouch Launches Revitalized Website for Sterling Life Insurance Company 3Health News:Ondine Biopharma Announces Sinuwave Technologies Spinout 2Health News:Ondine Biopharma Announces Sinuwave Technologies Spinout 3Health News:All Eyes on Hemlines, Not Henman, at Wimbledon This Year 2Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 2Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 3Health News:Electronic Cigarettes and the Declaration of Independence 2
(Date:5/5/2015)... Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that a 154-patient ... 3 chronic kidney disease patients with type 2 ... primary endpoint of decreasing the urinary albumin-creatinine ratio ... Ardelyx formed a partnership with ...
(Date:5/5/2015)... May 5, 2015 /CNW Telbec/ - Ergoresearch Ltd ... and known under the « Équilibre, ... of the transaction previously announced on April 23, 2015 ... outstanding  shares of Orthoconcept (2008) inc.   ... common shares (TSXV: ERG) to the vending shareholder, namely ...
(Date:5/5/2015)... , May 5, 2015  The preclinical contract research ... pharmacokinetic testing of drugs and safety testing of medical ... Director of Preclinical Studies, presented at this week,s annual ... Ophthalmology (ARVO) in Denver, CO. ... Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Medicine Products: